All Stories

  1. The Role of Calcium Handling Mechanisms in Reperfusion Injury
  2. The Role of Colchicine in the Prevention of Cerebrovascular Ischemia
  3. Colchicine Pharmacokinetics and Mechanism of Action
  4. Remote Ischemic Conditioning and Renal Protection
  5. Marked bradycardia elicited during pulmonary vein isolation: not a sign of success: authors' reply
  6. Usefulness of Colchicine to Reduce Perioperative Myocardial Damage in Patients Who Underwent On-Pump Coronary Artery Bypass Grafting
  7. Early pulmonary vein reconnection as a predictor of left atrial ablation outcomes for paroxysmal atrial fibrillation
  8. Reply to the Editor— Interatrial Block: An Anatomic-Electrical Entity Still in Need of Compelling Prospective Data
  9. Reply
  10. Effect of Angiotensin Converting Enzyme Inhibitors on Soluble Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand Levels - Association With Neointimal Hyperplasia in Drug Eluting Stents
  11. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty
  12. Innate Immune Inflammatory Response in the Acutely Ischemic Myocardium
  13. Exhaled Breath Condensate in Acute and Chronic Heart Failure: New Insights into the Role of Lung Injury and Barrier Dysfunction
  14. Interatrial conduction time and incident atrial fibrillation: A prospective cohort study
  15. Association of virtual histology characteristics of the culprit plaque with post-fibrinolysis flow restoration in ST-elevation myocardial infarction
  16. Do Not Miss the Elephant in the Room
  17. Fixed combination dual antiplatelet therapy and the risk of stent thrombosis
  18. Association of Quality of Life, Anxiety, and Depression with Left Atrial Ablation Outcomes
  19. Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators
  20. Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
  21. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: Mid-term efficacy and effect on quality of life
  22. Inflammation Markers in Essential Hypertension
  23. Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to “Cool” the Heart
  24. Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
  25. Treating Dyslipidemias: Is Inflammation the Missing Link?
  26. Reply
  27. Colchicine and the Heart
  28. The impact of vagotonic, adrenergic, and random type of paroxysmal atrial fibrillation on left atrial ablation outcomes
  29. Reply
  30. Reply
  31. Effectiveness of Moxonidine to Reduce Atrial Fibrillation Burden in Hypertensive Patients
  32. Association of post-cardioversion transcardiac concentration gradient of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) and inflammatory biomarkers to atrial fibrillation recurrence
  33. Renoprotective Effect of Remote Ischemic Post-Conditioning by Intermittent Balloon Inflations in Patients Undergoing Percutaneous Coronary Intervention
  34. Reply
  35. Pre-procedural flow-mediated dilation associated to arterial spasm during transulnar coronary angiography and interventions
  36. Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
  37. Adiponectin: Merely a Bystander or the Missing Link to Cardiovascular Disease?
  38. Cystatin C: An Emerging Biomarker in Cardiovascular Disease
  39. Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?
  40. MicroRNAs and the Heart: Small Things Do Matter
  41. NTproBNP: An Important Biomarker in Cardiac Diseases
  42. Myeloperoxidase: Expressing Inflammation and Oxidative Stress in Cardiovascular Disease
  43. Copeptin as a Biomarker in Cardiac Disease
  44. The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
  45. High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
  46. Moderate Procedural Sedation and Opioid Analgesia During Transradial Coronary Interventions to Prevent Spasm
  47. Colchicine for Prevention of Early Atrial Fibrillation Recurrence After Pulmonary Vein Isolation
  48. Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies
  49. Editorial (Hot Topic: The New Kids on the Block: Oral Direct IIa and Xa Inhibitors Enter the Proscenium of Anticoagulation Treatment)
  50. Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
  51. Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations
  52. Inverse Association of Coronary Soluble Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (sTRAIL) Levels to In-Stent Neointimal Hyperplasia
  53. Feasibility and procedure-related patient discomfort of peripheral venous access for coronary sinus cannulation during electrophysiology procedures
  54. The Authors' reply
  55. Sheathless transulnar versus standard femoral arterial access for percutaneous coronary intervention on bifurcation lesions
  56. Relation of Ventricular Tachycardia/Fibrillation to Beta-Blocker Dose Maximization Guided by Pacing Mode Analysis in Nonpacemaker-Dependent Patients With Implantable Cardioverter–Defibrillator
  57. Radial artery flow-mediated dilation predicts arterial spasm during transradial coronary interventions
  58. Feasibility and safety of transulnar access for performing rotational atherectomy
  59. Successful Retrieval of a Coronary Stent Dislodged in the Brachial Artery by Means of Improvised Snare and Guiding Catheter
  60. Clinical Determinants of Electrocardiographic and Spatial Vectorcardiographic Descriptors of Ventricular Repolarization in Healthy Children
  61. Comparison of Muscle Functional Electrical Stimulation to Conventional Bicycle Exercise on Endothelium and Functional Status Indices in Patients With Heart Failure
  62. Differential Effect of Biventricular and Right Ventricular DDD Pacing on Coronary Flow Reserve in Patients With Ischemic Cardiomyopathy
  63. EFFECT OF BIVENTRICULAR AND RIGHT VENTRICULAR PACING ON CORONARY FLOW RESERVE IN RESPONDERS AND NON-RESPONDERS TO CARDIAC RESYNCHRONIZATION THERAPY
  64. Prevalence of Interatrial Block in Healthy School-Aged Children: Definition by P-Wave Duration or Morphological Analysis
  65. Effect of Quinapril on In-Stent Restenosis and Relation to Plasma Apoptosis Signaling Molecules
  66. Cardioprotective Role of Remote Ischemic Periconditioning in Primary Percutaneous Coronary Intervention
  67. Adverse Bioeffects of Ultrasound Contrast Agents Used in Echocardiography: True Safety Issue or “Much Ado About Nothing”?
  68. Prognostic significance of inverse spatial QRS-T angle circadian pattern in myocardial infarction survivors
  69. Evolution of repolarization descriptors in myocardial infarction survivors
  70. Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
  71. Expanding the prognostic usefulness of the admission electrocardiogram in acute myocardial infarction
  72. Beat by Beat Variations
  73. Heart Rate Lowering by Inhibition of the Pacemaker Current: A New Therapeutic Perspective in Cardiovascular Disease
  74. The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation